
National institute of standards and technology/advanced technology program grant winning device
Totally Implantable Blood Pressure Sensor As a joint venture, Proven Process and APEX Medical have successfully completed initial animal tests of their totally implantable blood pressure device that will optimize operations of Left Ventricular Assist Devices (LVADs). Made of titanium, the device is being developed in part with funding awarded by the U.S. Department of Commerce's National Institute of Standards and Technology/Advanced Technology Program, following a national competition.
The device is the only known blood pressure monitor in development designed to fully integrate with an LVAD to assure direct, continuous measurement of blood pressure. An LVAD is used to treat congestive heart failure by working alongside a weakened heart, helping by pumping blood from the left ventricle. Five million Americans suffer from congestive heart failure today and 400,000 more are diagnosed with the disease each year. However, only about 2,500 hearts are available each year in the US for transplant, and as the population ages the incidence of heart disease is expected to increase.